Curative Biosciences ROE 2024

Curative Biosciences Aktienanalyse

What does Curative Biosciences do?

Curative Biosciences Inc is a biotechnology company specializing in the development of innovative therapies for serious diseases. The company was founded in 2011 by a group of experienced scientists, medical experts, and entrepreneurs and is based in San Francisco, California. History Curative Biosciences Inc aims to develop groundbreaking therapies for diseases that currently have no effective treatment options. The company has had an impressive track record in recent years, as evidenced by numerous awards and recognition from reputable institutions and media. Business Model Curative Biosciences Inc has developed a unique business model based on the combination of basic research, product development, and marketing. The company conducts intensive research to identify and develop promising drug candidates. Divisions Curative Biosciences Inc has focused on several divisions to offer a wide range of innovative therapy options: - Oncology: Curative Biosciences Inc has developed a portfolio of drug candidates that specifically target malignant tumors without damaging healthy tissue. - Autoimmune diseases: The company has also developed some promising drug candidates for autoimmune diseases that regulate the immune system and reduce the risk of side effects and complications. - Neurodegenerative diseases: Curative Biosciences Inc is intensively working on the development of therapies against neurodegenerative diseases such as Alzheimer's, Parkinson's, and ALS. Products The company has already developed several promising products that are currently in clinical trials. Here are some examples: - CB-01: A drug candidate specifically developed to target aggressive tumors such as lung cancer, pancreatic cancer, and leukemia. - CB-02: A drug candidate that regulates the immune system and could be used in the treatment of autoimmune diseases such as multiple sclerosis and rheumatoid arthritis. - CB-03: A promising drug candidate against Alzheimer's disease that reduces β-amyloid proteins in the brain and could slow down the progression of the disease. Summary Curative Biosciences Inc is an emerging biotechnology company specializing in the development of innovative therapies for serious diseases. The company conducts intensive research and has already developed several promising drug candidates that are currently in clinical trials. Curative Biosciences Inc has developed a unique business model based on the combination of basic research, product development, and marketing. Curative Biosciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Curative Biosciences's Return on Equity (ROE)

Curative Biosciences's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Curative Biosciences's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Curative Biosciences's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Curative Biosciences’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Curative Biosciences Stock

What is the ROE (Return on Equity) of Curative Biosciences this year?

The ROE of Curative Biosciences this year is 0 undefined.

How has the Return on Equity (ROE) of Curative Biosciences developed compared to the previous year?

The ROE of Curative Biosciences has increased by 0% decreased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Curative Biosciences?

A high ROE indicates that Curative Biosciences generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Curative Biosciences?

A low ROE can indicate that Curative Biosciences is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Curative Biosciences affect the company?

A change in ROE (Return on Equity) of Curative Biosciences can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Curative Biosciences?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Curative Biosciences?

Some factors that can influence Curative Biosciences's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Curative Biosciences pay?

Over the past 12 months, Curative Biosciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Curative Biosciences is expected to pay a dividend of 0 USD.

What is the dividend yield of Curative Biosciences?

The current dividend yield of Curative Biosciences is .

When does Curative Biosciences pay dividends?

Curative Biosciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Curative Biosciences?

Curative Biosciences paid dividends every year for the past 0 years.

What is the dividend of Curative Biosciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Curative Biosciences located?

Curative Biosciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von Curative Biosciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Curative Biosciences from 6/7/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/7/2024.

When did Curative Biosciences pay the last dividend?

The last dividend was paid out on 6/7/2024.

What was the dividend of Curative Biosciences in the year 2023?

In the year 2023, Curative Biosciences distributed 0 USD as dividends.

In which currency does Curative Biosciences pay out the dividend?

The dividends of Curative Biosciences are distributed in USD.